{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:25:17Z","timestamp":1794565517605,"version":"4.9.1"},"reference-count":12,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T00:00:00Z","timestamp":1384992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            To examine mortality and morbidity after prostate biopsy in the intervention arm of the\n                            <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>\n                            rostate,\n                            <jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>\n                            ung,\n                            <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                            olorectal and\n                            <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>\n                            varian\n                            <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                            ancer\n                            <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                            creening (\n                            <jats:styled-content style=\"fixed-case\">PLCO<\/jats:styled-content>\n                            ) trial.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Abstractors from the\n                            <jats:styled-content style=\"fixed-case\">PLCO<\/jats:styled-content>\n                            trial recorded the types and dates of diagnostic follow\u2010up procedures after positive screens and documented the types and dates of resultant complications. Cancers and deaths among the participants were tracked.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The mortality rate in the 120\u2010day period after prostate biopsy was compared with a control rate of deaths in the 120\u2010day period after a negative screen in men without biopsy.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Multivariate analysis was performed to control for potential confounders, including age, comorbidities and smoking.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Rates of any complication, infectious and non\u2010infectious complications were computed among men with a negative biopsy. Multivariate analysis was used to examine the risk factors for complications.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Of the 37\u2009345 men enrolled in the\n                            <jats:styled-content style=\"fixed-case\">PLCO<\/jats:styled-content>\n                            trial (intervention arm), 4861 had at least one biopsy after a positive screen and 28\u2009661 had a negative screen and no biopsy.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            The 120\u2010day mortality rate after biopsy was 0.95 (per 1000), compared with the control group rate of 1.8; the multivariate relative risk was 0.49 (95%\n                            <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                            : 0.2\u20131.1).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Among 3706 negative biopsies, the rates (per 1000) of any complication, infectious and non\u2010infections complications were 20.2, 7.8 and 13.0, respectively.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            A history of prostate enlargement or inflammation was significantly associated with higher rates of both infectious (odds ratio [\n                            <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                            ] = 3.7) and non\u2010infectious (\n                            <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                            = 2.2) complications. Black race was associated with a higher infectious complications rate (\n                            <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                            = 7.1) and repeat biopsy was associated with lower rates of non\u2010infectious complications (\n                            <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                            = 0.3).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Mortality rates were not found to be higher after prostate biopsy in the\n                            <jats:styled-content style=\"fixed-case\">PLCO<\/jats:styled-content>\n                            trial and complications were relatively infrequent, with several risk factors identified.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.12368","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T05:51:24Z","timestamp":1374213084000},"page":"254-259","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Mortality and complications after prostate biopsy in the\n                    <scp>P<\/scp>\n                    rostate,\n                    <scp>L<\/scp>\n                    ung,\n                    <scp>C<\/scp>\n                    olorectal and\n                    <scp>O<\/scp>\n                    varian\n                    <scp>C<\/scp>\n                    ancer\n                    <scp>S<\/scp>\n                    creening (\n                    <scp>PLCO<\/scp>\n                    ) trial"],"prefix":"10.1111","volume":"113","author":[{"given":"Paul F.","family":"Pinsky","sequence":"first","affiliation":[{"name":"Division of Cancer Prevention National Cancer Institute  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Parnes","sequence":"additional","affiliation":[{"name":"Division of Cancer Prevention National Cancer Institute  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Andriole","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine  St Louis MO USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,11,21]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2011.06.057"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.11.043"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10926.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d7894"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.12.058"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23559"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11513.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810696"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr500"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(00)00098-2"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2010.09712.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwk075"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.12368","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.12368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:25:48Z","timestamp":1761755148000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.12368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,21]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.1111\/bju.12368"],"URL":"https:\/\/doi.org\/10.1111\/bju.12368","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,21]]},"assertion":[{"value":"2013-11-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}